Yahoo Web Search

  1. Most American homeowners — 83% — wouldn't go back to renting after buying a home, according to the 2019 Fall Homebuyer Insights Report issued by Bank of America released Thursday. No ...

  2. Democrats: Americans Won’t Pay Your Carbon Taxes

    Bloomberg via Yahoo FinanceSep 08 13:00 PM

    Democratic politicians and strategists are aware that most people don’t want to see private health insurance banned, for example, but such leading contenders as Senators Elizabeth Warren ...

  3. Spokesman: Oil tycoon T. Boone Pickens dies at age 91

    Associated Press via Yahoo FinanceSep 11 19:50 PM

    T. Boone Pickens, a brash and quotable oil tycoon who grew even wealthier through corporate takeover attempts, died Wednesday. Pickens was surrounded by friends and family when he died ...

  4. Tech fund seekers should consider taking a look at T. Rowe Price Science & Technology Fund (PRSCX). PRSCX holds a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting ...

  5. You may want to consider T. Rowe Price Growth Stock Fund (PRGFX) as a possible option. PRGFX carries a Zacks Mutual Fund Rank of 3 (Hold), which is based on nine forecasting factors like ...

  6. Oil tycoon T. Boone Pickens dead at 91

    Yahoo FinanceSep 11 18:27 PM

    T. Boone Pickens, the billionaire tycoon who made his fortune in fossil fuels — only to spend his latter years advocating passionately for alternative energy — died on Wednesday, his ...

  7. T. Rowe Price International Discovery (PRIDX) is a possible starting point. PRIDX holds a Zacks Mutual Fund Rank of 3 (Hold), which is based on nine forecasting factors like size, cost ...

  8. AP Analysis: US-UK trade deal won't be so easy post-Brexit

    Associated Press via Yahoo FinanceSep 07 14:37 PM

    Britain hasn't even divorced the European Union yet, and already a new suitor has come calling: the United States. During a visit this week to the United Kingdom, Vice President Mike ...

  9. Health funds, a place to start could be Janus Henderson Global Life Science T (JAGLX). JAGLX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine forecasting factors ...

  10. Shares of Adaptimmune Therapeutics plc ADAP rose about 8% after the company announced that the FDA has granted Orphan Drug Designation (ODD) to SPEAR T-cells targeting MAGE-A4 (ADP-A2M4 ...